Connect with us

Bloomberg Technology

Coinbase’s Valuation Big Bet On Nascent Player: Cleo Capital

Apr.12 — Cleo Capital Managing Director Sarah Kunst discusses Coinbase’s upcoming IPO, its $100 billion valuation, and how the listing may change the cryptocurrency space. She speaks to Caroline Hyde and Sonali Basak on “Bloomberg Technology.”

Published

on

Apr.12 — Cleo Capital Managing Director Sarah Kunst discusses Coinbase’s upcoming IPO, its $100 billion valuation, and how the listing may change the cryptocurrency space. She speaks to Caroline Hyde and Sonali Basak on “Bloomberg Technology.”

Continue Reading
Advertisement
7 Comments

7 Comments

  1. ronald iskandar

    April 13, 2021 at 12:07 am

    Coinbase go go go

  2. Christopher Lynch

    April 13, 2021 at 12:22 am

    0:49
    vor.ind.in

  3. Henry Houdini

    April 13, 2021 at 12:57 am

    The price of Bitcoin (BTC) has surpassed US$61,OOO on April 1O for the first time in nearly a month. Following the breakout, traders are starting to look at new levels of resistance and support in the short-term as optimism returns to the market. In the near term, besides the all-time high at around US$61,8OO, there are three key Bitcoin price levels to observe: US$61,188, US$58,387 and US$53,OOO. As long as the price of Bitcoin stays above US$58,387 and keeps attempting to break out above US$61,188, it would likely see a new record high in the foreseeable future. My Advice to Beginners, Old Investors, and Long Term HODLERS , if you want to make more Gains with what you have already Invested, You will need the support and Counsel from a Great-Crypto Mentor and coach like mine. “ (Dr. Mike Laury )” will guide you through any difficulties in Trading, I have made over USD 46O, OOO in Btc profit since the November Rally, with the 1BTC I bought at 12,780 USD, Thanks to my Mentor and Counsellor [ *@Mikelaurycrypto* ] on Telegram, I found his advice very helpful in my situation 🤑🤑🤑🤑🚀

    • Cedrick Warner

      April 13, 2021 at 12:59 am

      Hello Mike, hope you get this, I have only been a subscriber on your program for a couple months. I always trade stocks on technical basis anyway and have used your buy signals on about eight stocks over these two months and have made money on six of them and slight loss on two. So I use your signals as buys on trading stocks and adding to long term core positions when signals are in buy zone. They were very profitable, thanks .

    • Michael Alfonso

      April 13, 2021 at 12:59 am

      As a recent user of Dr. Mike’s Program I have found a resource which appears to be quite rewarding and thus am a happy camper. A few misunderstandings of the content led me to some small mistakes. However, I have already profited from the information provided either in savings (selling before sizeable losses occurred) or in better investments. As I have learned more I have hopes of future benefits and rewards. I like what has been provided so far.

    • Michelle Carter

      April 13, 2021 at 12:59 am

      Since I intend to use your service for the rest of my life, I have to admit I sometimes worry that you might decided to retire. I do hope you plan to put that day quite far off into the future. I remain one very satisfied student of yours.”

    • Jeff Berwick

      April 13, 2021 at 1:00 am

      I’ve been storing some Btc on Coinbase for a while waiting for a nice perfect time to invest, but I can’t seem to know how or when. I feel I could be growing it in a way, than to keep it just laying there , Thanks for the Info.

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Jd.com beats on #earnings #technology #alibaba

JD.com reported a better-than-anticipated 7% rise in revenue, after it slashed prices and ramped up shopper perks to counter fierce competition during a Chinese downturn. Bloomberg’s @EdLudlow has more.

Published

on

JD.com reported a better-than-anticipated 7% rise in revenue, after it slashed prices and ramped up shopper perks to counter fierce competition during a Chinese downturn. Bloomberg’s @EdLudlow has more.

Continue Reading

Bloomberg Technology

Microsoft’s Nadella says #AI should be called something else #technology #shorts

More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don’t miss any videos from Bloomberg Markets & Finance: Visit for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X: Facebook: Instagram: Connect with Bloomberg Business on: X: Facebook: Instagram: TikTok:…

Published

on

More on Bloomberg Television and Markets

Like this video? Subscribe and turn on notifications so you don’t miss any videos from Bloomberg Markets & Finance:
Visit for business news & analysis, up-to-the-minute market data, features, profiles and more.

Connect with Bloomberg Television on:
X:
Facebook:
Instagram:

Connect with Bloomberg Business on:
X:
Facebook:
Instagram:
TikTok:
Reddit:
LinkedIn:

Continue Reading

Bloomberg Technology

Neuralink’s first patient speaks about how Elon Musk’s brain implant changed his life #technology

Neuralink’s first patient told Bloomberg Businessweek how Elon Musk’s brain implant has changed his life. In this episode of the Elon, Inc. podcast, Ashlee Vance discusses what the future may be like for Musk’s startup and its patient Read more: Get more here: Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the…

Published

on

Neuralink’s first patient told Bloomberg Businessweek how Elon Musk’s brain implant has changed his life. In this episode of the Elon, Inc. podcast, Ashlee Vance discusses what the future may be like for Musk’s startup and its patient

Read more:

Get more here:

Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the first person to get Elon Musk’s Neuralink technology implanted in his head. Our own Ashlee Vance spent time with Arbaugh, who lives with his parents and (as you’ll hear) some vocal farm animals. Vance joins us to talk about what he learned from the first patient in Neuralink’s inaugural clinical trial. He is joined by Bloomberg’s Sarah McBride to give a full picture on what it all means. Plus, we talk to markets reporter Kiel Porter and space reporter Loren Grush about all of the action around SpaceX stock—which is kind of interesting since it’s still a private company.

Continue Reading

Trending